Posted by & filed under Company Analysis, Growth & Valuation, Industry Analysis.

Description: Pfizer Inc. and Allergan PLC said Monday that they would merge in a so-called inversion deal worth about $155 billion that would create the world’s biggest drug maker by sales.


Date: Nov 23, 2015


Questions for discussion:

  • What is an “inversion deal”?
  • What motivated this merger?
  • Do you think it suggests anything about the state of affairs in the industry?

Leave a Reply

Your email address will not be published. Required fields are marked *